Tal Gavoli

And by the way, WebMD doesn't do that for the latest research.

So if you understand, WebMD's information is essentially fairly static.

There's a page about lymphoma and about treatment options, but it doesn't get updated every research paper that gets updated.

Now, as an individual, I care if there's something that could affect my personal care or my loved one.

That's what we do.

And we basically interpret research and create these summaries that are useful for patients.

And those are the things that our original content that Medivisor consistently creates.

We won't get into that, but it's a substantial long-term engagement.

Okay.

It's basically a monthly subscription to this content for them.

Okay, what we provide them is not the personalized aspect.

For the personalization, they refer back to us, okay?

So these individuals that are coping, they can get unpersonalized content there.

And if they want it personalized, they come to us and subscribe.

So they're also referring essentially people, more subscribers to MetaVisor as part of this process as well.

What they license is unpersonalized.

It's not the number of searches per month, not the number of people that they serve either.

Basically, a specific SLA of a service that they get, of an information feed.

It may be.

It depends, again, on the way we're modeling it for them.